A?(39-42) modulates A? oligomerization but not fibril formation.
Ontology highlight
ABSTRACT: Recently, certain C-terminal fragments (CTFs) of A?42 have been shown to be effective inhibitors of A?42 toxicity. Here, we examine the interactions between the shortest CTF in the original series, A?(39-42), and full-length A?. Mass spectrometry results indicate that A?(39-42) binds directly to A? monomers and to the n = 2, 4, and 6 oligomers. The A?42:A?(39-42) complex is further probed using molecular dynamics simulations. Although the CTF was expected to bind to the hydrophobic C-terminus of A?42, the simulations show that A?(39-42) binds at several locations on A?42, including the C-terminus, other hydrophobic regions, and preferentially in the N-terminus. Ion mobility-mass spectrometry (IM-MS) and electron microscopy experiments indicate that A?(39-42) disrupts the early assembly of full-length A?. Specifically, the ion-mobility results show that A?(39-42) prevents the formation of large decamer/dodecamer A?42 species and, moreover, can remove these structures from solution. At the same time, thioflavin T fluorescence and electron microscopy results show that the CTF does not inhibit fibril formation, lending strong support to the hypothesis that oligomers and not amyloid fibrils are the A? form responsible for toxicity. The results emphasize the role of small, soluble assemblies in A?-induced toxicity and suggest that A?(39-42) inhibits A?-induced toxicity by a unique mechanism, modulating early assembly into nontoxic hetero-oligomers, without preventing fibril formation.
SUBMITTER: Gessel MM
PROVIDER: S-EPMC3271797 | biostudies-literature | 2012 Jan
REPOSITORIES: biostudies-literature
ACCESS DATA